Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

L3MBTL2 Mouse anti-Human, Clone: 4F4, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA522704

Catalog No. PIMA522704


Add to cart

Description

Description

Peptide Sequence: RQGSKKPLLE DDPQGARKIS SEPVPGEIIA VRVKEEHLDV ASPDKASSPE LPVSVENIKQ ETDD

Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated  ft.Lys-20 ft. on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on  ft.Lys-4 ft.,  ft.Lys-9 ft. or  ft.Lys-27 ft..
Specifications

Specifications

L3MBTL2
Monoclonal
0.2-1.0 mg/mL
PBS with no preservative; pH 7.4
Q969R5
H-l(3)mbt-l, L3MBT, H-l(3)mbt-like protein 2, L(3)mbt-like protein 2, lethal(3)maligt brain tumor-like protein 2
Mouse
IgG1, kappa
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
83746
ELISA, Western Blot
4F4
Unconjugated
L3MBTL2
Liquid
L3MBTL2
L3MBTL2 (NP_113676, 642 a.a. ∽ 705 a.a) partial recombit protein with GST tag. MW of the GST tag alone is 26 KDa.
Affinity chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit